SO
CGEM icon

STRS Ohio’s Cullinan Oncology CGEM Stock Holding History

STRS Ohio’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-34,100
Closed -$595K – 1982
2024
Q2 		$595K Buy
34,100
+2,200
+7% +$46.8K ﹤0.01% 1108
2024
Q1 		$543K Buy
+31,900
New +$493K ﹤0.01% 1200
2021
Q4 		– Sell
-3,700
Closed -$83K – 2206
2021
Q3 		$83K Buy
3,700
+500
+16% +$13.4K ﹤0.01% 1975
2021
Q2 		$82K Hold
3,200
– – ﹤0.01% 2018
2021
Q1 		$133K Buy
+3,200
New +$130K ﹤0.01% 1884

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

STRS Ohio's CGEM Position: Q3 2024 in Review

STRS Ohio sold out of Cullinan Oncology (CGEM) in Q3 2024, closing a stake of 34,100 shares — an estimated $595K sold.

STRS Ohio first reported a position in CGEM in Q1 2021 and held it in 5 quarters. The position peaked at $595K in Q2 2024. 137 funds tracked by Wall St. Rank hold CGEM as of Q3 2024.

  • STRS Ohio reported no remaining Cullinan Oncology position as of Q3 2024 after selling out during the quarter.
  • STRS Ohio sold 34,100 Cullinan Oncology shares in Q3 2024, an estimated $595K.
  • STRS Ohio first reported a position in Cullinan Oncology in Q1 2021 and held it in 5 quarters.
  • STRS Ohio's Cullinan Oncology position peaked at $595K in Q2 2024.
  • 137 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2024.

Based on STRS Ohio's 13F filing for Q3 2024, filed 1 Nov 2024.